Quantcast

Latest Kiran Mazumdar-Shaw Stories

2014-05-19 16:21:44

PHILADELPHIA, May 19, 2014 /PRNewswire-USNewswire/ -- Each year the Chemical Heritage Foundation (CHF) presents awards to innovators and leaders in the molecular sciences on Heritage Day. This year's awardees, who were honored on May 15, represent the highest achievement in very different fields. http://photos.prnewswire.com/prnvar/20140519/88877 Ronald Breslow, University Professor at Columbia University, was this year's recipient of the American Institute of Chemists (AIC)...

2014-05-16 23:03:55

The U.S. Pharmacopeial Convention (USP) congratulates Kiran Mazumdar-Shaw on receipt of the 2014 Othmer Gold Medal. Rockville, Md. (PRWEB) May 16, 2014 The U.S. Pharmacopeial Convention (USP) congratulates Kiran Mazumdar-Shaw on receipt of the 2014 Othmer Gold Medal. Established by the Chemical Heritage Foundation (CHF) in 1997, the award honors outstanding individuals who have made multifaceted contributions to chemical and scientific heritage through outstanding activity in such areas...

2014-01-21 16:21:23

She will accept CHF's top award at a dinner ceremony, the premier event of Heritage Day 2014 in Philadelphia. PHILADELPHIA, Jan. 21, 2014 /PRNewswire-USNewswire/ -- Kiran Mazumdar-Shaw, chairman and managing director, Biocon Limited, will receive the 2014 Othmer Gold Medal at the Chemical Heritage Foundation on Thursday, May 15. The Othmer Gold Medal presentation will be the premier event of CHF's 13th annual Heritage Day. (Photo:...

2010-10-18 06:00:00

BANGALORE, India and NEW YORK, Oct. 18 /PRNewswire/ -- Biocon, Asia's premier biotechnology company, and Pfizer Inc. (NYSE: PFE), the world's leading biopharmaceutical company, today announced that they have entered into a strategic global agreement for the worldwide commercialization of Biocon's biosimilar versions of Insulin and Insulin analog products: Recombinant Human Insulin, Glargine, Aspart and Lispro. Pfizer will have exclusive rights to commercialize these products globally,...

2010-05-24 07:00:00

SAN DIEGO and BANGALORE, India, May 24 /PRNewswire-FirstCall/ -- Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) a biopharmaceutical company focused on the treatment of serious infections such as Clostridium difficile infection (CDI), and Biocon Limited (NSE: BIOCON), one of India's premier biotechnology companies and a global provider of manufacturing services, announced today that they have entered into a long-term supply agreement for the commercial manufacturing of the active...

2009-09-10 15:15:00

SAN DIEGO and BANGALORE, India, Sept. 10 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Biocon, Limited (NSE: BIOCON) announced today that they have entered into an exclusive agreement to jointly develop, commercialize and manufacture a novel peptide therapeutic for the potential treatment of diabetes. Amylin and Biocon will collaborate to develop the therapeutic potential of the compound and share development costs. Research will center on Amylin's "phybrid"...

2009-06-29 05:30:00

PITTSBURGH, June 29 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that it has executed a definitive agreement with Biocon Limited, a publicly traded company on the Indian stock exchanges, for an exclusive collaboration on the development, manufacturing, supply and commercialization of multiple, high value generic biologic compounds for the global marketplace. Through this partnership, Mylan and Biocon bring together highly complementary capabilities that will...

2008-07-18 09:01:12

Biocon and Abraxis BioScience have launched Abraxane in India for the treatment of breast cancer after failure of combination therapy for metastatic disease or relapse within six months of adjuvant chemotherapy. Abraxane is now available in India as a single-use 100mg vial (as a lyophilized powder, to be reconstituted for intravenous administration). In October 2007, Abraxane was approved by the Drug Controller General of India. The approval was based on the clinical trial data that was...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related